Following a request for better clarity around ethics and informed consent in obtaining the patient samples, the authors would like to add the following information to the above mentioned paper: “Informed consent and Institutional Review Board (IRB)/Ethics Committee approval were obtained.”
. 2022 Sep 28;26:35. doi: 10.1016/j.jmsacl.2022.08.002
Corrigendum to “Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease” [Clin. Mass Spectrom. 14 (Part B) (2019) 74–82]
Karl Hansson
a, Rahil Dahlén
a, Oskar Hansson
b,c, Elin Pernevik
a, Ross Paterson
d, Jonathan M Schott
d, Nadia Magdalinou
e, Henrik Zetterberg
a,f, Kaj Blennow
a,f, Johan Gobom
a,f,⁎
Karl Hansson
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Find articles by Karl Hansson
Rahil Dahlén
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Find articles by Rahil Dahlén
Oskar Hansson
bClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
cMemory Clinic, Skåne University Hospital, Malmö, Sweden
Find articles by Oskar Hansson
Elin Pernevik
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Find articles by Elin Pernevik
Ross Paterson
dDementia Research Centre, UCL Institute of Neurology, London, UK
Find articles by Ross Paterson
Jonathan M Schott
dDementia Research Centre, UCL Institute of Neurology, London, UK
Find articles by Jonathan M Schott
Nadia Magdalinou
eReta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, Queen Square, London, UK
Find articles by Nadia Magdalinou
Henrik Zetterberg
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
fClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Find articles by Henrik Zetterberg
Kaj Blennow
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
fClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Find articles by Kaj Blennow
Johan Gobom
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
fClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
Find articles by Johan Gobom
aInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
bClinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
cMemory Clinic, Skåne University Hospital, Malmö, Sweden
dDementia Research Centre, UCL Institute of Neurology, London, UK
eReta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, Queen Square, London, UK
fClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden
⁎
Corresponding author at: Institute of Neuroscience and Physiology, Department of Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 80 Mölndal, Sweden. johan.gobom@neuro.gu.se
Collection date 2022 Nov.
© 2022 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC9523399 PMID: 36187744
This corrects the article "Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease" in Clin Mass Spectrom, volume 14 Pt B on page 74.